| | 
Part, Chapter, Paragraph
1 I, 2. 7 | high level, ranging from 49% (Slovenia) to 97% (Belgium)
2 II, 4. 1 | women, representing 53% and 49% of the total life expectancy
3 II, 5. 2. 3 | Central Europe (from 133 to 49 per 100.000), 40% in Southern
4 II, 5. 4. 3 | ranges from 35% (Belgium) to 49% (Ireland), with median
5 II, 5. 5.Int(15)| World Psychiatry, 3:45–49.~
6 II, 5. 5.Int(18)| non-Western countries.MedGenMed.6:49.~
7 II, 5. 5. 3 | and again between 45 and 49 years of age with a continuous
8 II, 5. 5. 3 | Epilepsia 44 (suppl 6):49-50.~Barraclough BM (1987):
9 II, 5. 5. 3 | for the population aged 35–49 for all Countries taken
10 II, 5. 5. 3 | Evros, Greece. Eur Neurol 49:8-12.~Poser CM, Paty DW,
11 II, 5. 5. 3 | disease. Br J Clin Pract 49(6):288-293.~Claveria LE,
12 II, 5. 8. 5 | compared with a decrease of 49 ml FEV1 among continuing
13 II, 5. 9. 3 | 45.8% (41.6% in women and 49.5% in men, P 001). Asthmatic
14 II, 5. 11. 3 | Contact Dermatitis, 2003; 49:107–108.~R Silva, F Pere a,
15 II, 6. 3. 1 | overview of trends for the 49 diseases under surveillance (
16 II, 6. 3. 1 | surveillance (Table 6.1). Of the 49 diseases, 21 have incidence
17 II, 6. 3. 7 | highest incidence rates (0.49 per 100 000 and 0.48 per
18 II, 8. 2. 1 | Intellectual Disability Research 49, 134–143.~Emerson, E. and
19 II, 8. 2. 2 | 1.6% for people aged 40-49 and 3.6% for people aged
20 II, 8. 2. 2 | 1.6% for people aged 40-49 and 3.6% for people aged
21 II, 9 | the last 30 days between 49% in Austria and 22% in Cyprus (
22 II, 9. 1. 1 | mortality. J Reprod Med 2004;49(10):812-6.~Maher J, Macfarlane
23 II, 9. 2. 4 | the last 30 days between 49% in Austria and 22% in Cyprus (
24 II, 9. 3. 1 | aged 30-39, 9.5% aged 40-49, 15.7% aged 50-59, 34.4%
25 II, 9. 3. 1 | in women between 20 and 49 years of age, and according
26 II, 9. 3. 1 | General Medicine; 6: 3: 49.~ ~Men and Gender Equality
27 II, 9. 3. 2 | mortality. J Reprod Med 2004;49(10):812-6.~ ~Maher J, Macfarlane
28 II, 9. 3. 3 | 1989 and 1993 in the 18-49 age group (Hubert M et al,
29 II, 9. 3. 3 | countries. AIDS Care 6(5) :533-49.~Bozon M, Kontula O (1998):
30 II, 9. 5. 3 | 10 minutes or more, while 49% spent in excess of 4.5
31 II, 9. 5. 3 | physical activity showed that 49% of the EU population get
32 II, 9. 5. 3 | the least in Lithuania (3h:49). The main domestic tasks
33 III, 10. 1. 3 | dependence. J Addict Dis 10(3):49-61.~Parsons TJ, Power C,
34 III, 10. 2. 1 | Strategy Monograph Series No. 49. Canberra: Commonwealth
35 III, 10. 2. 1 | mortality among adults aged 15-49 could be attributed to opioids
36 III, 10. 2. 1 | active 15-year-old boys was 49% in the Czech Republic and
37 III, 10. 2. 1 | und Sporttraumatologie, 49(3):131-133.~ ~Maxwell K,
38 III, 10. 2. 1 | Dolman et al, 2007), Hungary (49.5%) (Rodler at al, 2005),
39 III, 10. 2. 1 | Rodler at al, 2005), Malta (49.4%) (Asciak et al, 2003)
40 III, 10. 2. 1 | of Nutrition & Metabolism 49:71–76.~ ~National Institute
41 III, 10. 2. 1 | Epidémiologie et de Santé Publique 49:33-40.~ ~Padez C, Fernandes
42 III, 10. 2. 5 | factors. Diabetologia 2006;49:2853 - 8~ ~Gale CR, Martyn
43 III, 10. 3. 1 | Directive, Directive 2002/49/EC on~LAeq~A-weighted average
44 III, 10. 3. 1 | J. Occup. Environ. Med., 49, 266-274.~Torfs R (2003).
45 III, 10. 3. 2 | concentrations of for S-PBDE of 2.49 ng/g fat which is comparable
46 III, 10. 3. 3 | communicable diseases. Of the 49 diseases under surveillance
47 III, 10. 5. 3 | from 2.0% in Slovakia to 49.8% in the Netherlands.~·
48 IV, 11. 1. 5 | results, with one report of a 49% error rate in the administration
49 IV, 12. 1 | health professionals;~ ~Art. 49 and 50 (services, including
50 IV, 12. 10 | environmental noise (2002/49/EG) is being implemented
51 IV, 13. 2. 3 | have been calculated for 49 selected conditions. Table
|
|
| |
